Use of istradefylline for treating behavioral disorders
AssigneeKyowa Hakko Kogyo Co., Ltd.
InventorsShizuo Shiozaki, Junichi Shimada, Hiroshi Kase, Mayumi Shindo
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of treating behavioral disorders such as attention deficit hyperactivity disorder, comprising administering an effective amount of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine or a pharmaceutically acceptable salt thereof to a patient in need thereof and the like.
Claims4
A method of treating attention deficit hyperactivity disorder, comprising administering an effective amount of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine, or a pharmaceutically acceptable salt thereof, to a patient in need thereof.
2-6. (canceled)
A method of treating Tic/Tourette's disorder, comprising administering an effective amount of (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine, or a pharmaceutically acceptable salt thereof, to a patient in need thereof.
8-9. (canceled)
Dependencies are inferred from the claim text.